Addus HomeCare (ADUS) vs GeneDx (WGS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Addus HomeCare (ADUS) has outperformed GeneDx (WGS) over the past year, gaining 2.4% versus a loss of 43.3%. Over five years, ADUS leads with a +47.1% price change compared with -73.3% for WGS. Addus HomeCare is the larger company by market cap ($2.15 billion vs $2.00 billion), about 1.1 times the size.
On valuation, Addus HomeCare trades at a lower forward P/E (15.3x vs 55.9x for GeneDx).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADUS | WGS |
|---|---|---|
| Share price | $115.33 | $66.95 |
| Market cap | $2.15B | $2.00B |
| 1-day change | +1.82% | -2.31% |
| YTD return | +5.48% | -47.31% |
| 1-year return | +2.38% | -43.25% |
| 5-year return | +47.10% | -73.34% |
| P/E ratio (TTM) | 20.20 | — |
| Forward P/E | 15.29 | 55.86 |
| EPS (TTM) | $5.71 | $-3.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $124.44 | $170.87 |
| 52-week low | $87.95 | $32.21 |
| Distance from 52-week high | -7.32% | -60.82% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +16.26% | +39.66% |
| Average volume | 218.88K | 728.47K |
| Shares outstanding | 18.67M | 29.82M |
| Employees | 5,982 | 1,300 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ADUS has outperformed WGS by 45.6 percentage points over the past year.
About Addus HomeCare
ADUS stock →Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Health Care · Medical/Nursing Services · 5,982 employees
About GeneDx
WGS stock →GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.
Health Care · Medical/Nursing Services · 1,300 employees
ADUS vs WGS FAQ
Which is bigger, Addus HomeCare or GeneDx?
Addus HomeCare (ADUS) is larger, with a market capitalization of $2.15B compared with $2.00B for GeneDx (WGS).
Which stock has performed better over the past year, ADUS or WGS?
ADUS returned +2.38% over the past 12 months, compared with -43.25% for WGS (price return, excluding dividends). Past performance does not predict future results.
Are Addus HomeCare and GeneDx in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.